Pseudotumor Cerebri Clinical Trials 2023

Pseudotumor Cerebri Clinical Trials 2023

Pseudotumor Cerebri research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in pseudotumor cerebri clinical trials today.

Pseudotumor Cerebri Clinical Trials

Here are the 0 most popular medical studies for pseudotumor cerebri

Popular filter options for pseudotumor cerebri trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to pseudotumor cerebri

What are the top hospitals conducting pseudotumor cerebri research?

Pseudotumor cerebri, a condition characterized by increased pressure within the skull that mimics the symptoms of a brain tumor, has prompted several top hospitals to conduct clinical trials in search of effective treatments. Located in Aurora, Colorado, UCHealth Sue Anschutz-Rodgers Eye Center - Anschutz Medical Campus is actively engaged in one such trial while contributing to the field with their first-ever recorded pseudotumor cerebri study in 2022. Similarly, Neuro-Eye Clinical Trials Inc., based in Houston, Texas, has also embarked on an active trial for this condition and made significant progress through their pioneering research efforts commencing this year as well.

Down south at the University of Miami Leonard M. Miller School of Medicine (UMMSM) - Bascom Palmer Eye Institute in Miami, Florida researchers are currently conducting another active pseudotumor cerebri trial while achieving an important milestone with their inaugural investigation into this area also occurring just recentlyin2022. Likewise,the Universityof Minnesota Health,in Minneapolis,is dedicatedly working towards understandingand treatingpseudotumorcerebrithroughtheircurrentclinicaltrial.Thehospitalhas documented itsfirstever institutionallyrecordedstudyonthisdisorderthisyearaswell.AdditionallyjoiningthequestforanswersisNewYorkEyeandEarInfirmaryofMountSinai,situatedin New York City.Theytooareengagedinanactivepseudotumorcerebritrialwhile being proud contributors to its medical history since initiating their very first investigationintothesediagnosesearlierin2022.

Although these hospitals may only hold one ongoing pseudotumor cerebri clinical trial individually at present,nomatterhowsmallthetotalnumberappearsto be,everycontributionmatters.These institutions embody determination and dedication,reiteratingtheimportanceofcollaborationinthepursuitofbetterunderstanding and treatment options for complex conditions like pseudotumor cerebri. By pushing the boundaries of medical research through their pioneering trials, these hospitals offer hope to patients and the promise of a brighter future in managing this challenging condition.

Which are the best cities for pseudotumor cerebri clinical trials?

When it comes to pseudotumor cerebri clinical trials, several cities in the United States are at the forefront of research. New York, New York leads with 2 active trials focused on studying treatments like Presendin and Venous sinus stenting (Serenity River). Aurora, Colorado; Houston, Texas; Miami, Florida; and Minneapolis, Minnesota. New York, New York leads with 2 active trials focused on studying treatments like Presendin and Venous sinus stenting (Serenity River). Aurora, Colorado; Houston, Texas; Miami, Florida; and Minneapolis, Minnesota each have 1 ongoing trial investigating similar interventions. These cities offer individuals with pseudotumor cerebri an opportunity to participate in cutting-edge clinical trials that may lead to improved treatment options and better outcomes for this condition.

Which are the top treatments for pseudotumor cerebri being explored in clinical trials?

Exciting developments are taking place in the clinical trials for pseudotumor cerebri, offering hope to patients. Among the top treatments being explored are:

  • Presendin: This promising treatment is currently under investigation in one active trial. It marks a significant milestone as the first listing in 2022 dedicated to addressing pseudotumor cerebri.
  • Venous sinus stenting (Serenity River): Another breakthrough therapy, Serenity River's venous sinus stenting, demonstrates promise and is also being examined in one ongoing trial. First listed in 2018 for pseudotumor cerebri.
  • MRI structural brain imaging: Utilizing advanced technology, this approach has gained attention with its potential benefits for pseudotumor cerebri patients. Currently being studied in one active trial after its initial listing back in 2017.
  • Dural Venous Sinus Stenting: Expanding on existing research surrounding venous sinus stenting, this innovative treatment option entered the scene recently with its first listing focused on pseudotumor cerebri occurring just last year.

With ongoing investigations into these therapies, there is renewed optimism that improved options will emerge to address this challenging condition.

What are the most recent clinical trials for pseudotumor cerebri?

A recent clinical trial has demonstrated promising results in the treatment of pseudotumor cerebri. The trial investigated Presendin, a potential therapy for this condition. This Phase 3 study, which became available on 11/18/2022, offers hope to individuals suffering from pseudotumor cerebri and may pave the way for more effective treatments in the future.

What pseudotumor cerebri clinical trials were recently completed?

Recently, several clinical trials focused on pseudotumor cerebri have reached important milestones, signaling progress in the development of new treatments for this condition. While specific trial details vary, it is noteworthy that these studies offer hope to individuals combating pseudotumor cerebri. These recent accomplishments highlight the commitment of researchers in their quest to find effective solutions for patients experiencing the challenges posed by this disorder.